4.0 Article

Differential Involvement of Optineurin in Amyotrophic Lateral Sclerosis With or Without SOD1 Mutations

Journal

ARCHIVES OF NEUROLOGY
Volume 68, Issue 8, Pages 1057-1061

Publisher

AMER MEDICAL ASSOC
DOI: 10.1001/archneurol.2011.178

Keywords

-

Funding

  1. National Institutes of Health [NS050641, AG13854, T32 AG20506]
  2. Les Turner ALS Foundation
  3. ALS Association
  4. Vena E. Schaff ALS Research Fund
  5. Harold Post Research Professorship
  6. Herbert and Florence C. Wenske Foundation
  7. David C. Asselin MD Memorial Fund
  8. Les Turner ALS Foundation/Herbert
  9. Florence C. Wenske Professorship

Ask authors/readers for more resources

Background: Mutations in optineurin have recently been linked to amyotrophic lateral sclerosis (ALS). Objective: To determine whether optineurin-positive skeinlike inclusions are a common pathologic feature in ALS, including SOD1-linked ALS. Design: Clinical case series. Setting: Academic referral center. Subjects: We analyzed spinal cord sections from 46 clinically and pathologically diagnosed ALS cases and ALS transgenic mouse models overexpressing ALS-linked SOD1 mutations G93A or L126Z. Results: We observed optineurin-immunoreactive skeinlike inclusions in all the sporadic ALS and familial ALS cases without SOD1 mutation, but not in cases with SOD1 mutations or in transgenic mice overexpressing the ALS-linked SOD1 mutations G93A or L126Z. Conclusion: The data from this study provide evidence that optineurin is involved in the pathogenesis of sporadic ALS and non-SOD1 familial ALS, thus supporting the hypothesis that these forms of ALS share a pathway that is distinct from that of SOD1-linked ALS.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.0
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available